FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and can be applied for treatment of type 2 diabetes mellitus. Composition containa as active substances N-(β-oxyethyl)-4,6-dimethyldihydropyrimedone-2 (xymedon) and inulin in ratio (2.5-5):(1-3). Composition can additionally contain magnesium, zinc, chromium asparaginates and can be made in form of capsules or pills.
EFFECT: effect from application of pharmaceutical composition for treatment of type 2 diabetes mellitus consists in continuous reduction of glucose level in blood and normalisation of lipid metabolism parameters.
13 ex, 3 tbl
Authors
Dates
2011-12-10—Published
2009-07-21—Filed